Chronic fluoxetine selectively upregulates dopamine D 1-like receptors in the hippocampus

Neuropsychopharmacology

Volumn 37, Issue 6, 2012, Pages 1500-1508

  Kobayashi, Katsunori ^a,b   Haneda, Eisuke ^a   Higuchi, Makoto ^c   Suhara, Tetsuya ^c   Suzuki, Hidenori ^a,b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

antidepressant; dentate gyrus; dopamine; hippocampus; mossy fiber; SSRI

Indexed keywords

DOPAMINE 1 RECEPTOR; FLUOXETINE; LIGAND; PAROXETINE; SEROTONIN 4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DENTATE GYRUS; DRUG SELECTIVITY; DRUG WITHDRAWAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOSSY FIBER; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; AUTORADIOGRAPHY; BENZAZEPINES; BIOPHYSICS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FLUOXETINE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOSSY FIBERS, HIPPOCAMPAL; PAROXETINE; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; RECEPTORS, DOPAMINE D1; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; TRITIUM; UP-REGULATION;

EID: 84863407526     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.335     Document Type: Article

References (55)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM (2008). Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63: 642-649. (Pubitemid 351329281)
2. Ainsworth K, Smith SE, Zetterström TSC, Pei Q, Franklin M, Sharp T (1998). Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology (Berl) 140: 470-477. (Pubitemid 28566846)
3. Chen CC, Yang CH, Huang CC, Hsu KS (2010). Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity. Neuropsychopharmacology 35: 1605-1617.
4. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA (2002). cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22: 3262-3268. (Pubitemid 35379213)
5. D'Aquila PS, Collu M, Gessa GL, Serra G (2000). The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405: 365-373.
6. D'Aquila PS, Collu M, Pani L, Gessa GL, Serra G (1994). Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. Eur J Pharmacol 262: 107-111. (Pubitemid 24271842)
7. Deslandes PN, Pache DM, Buckland P, Sewell RDE (2002). Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission. Eur J Pharmacol 453: 223-229. (Pubitemid 35223514)
8. Do T, Kerr B, Kuzhikandathil EV (2007). Brain-derived neurotrophic factor regulates the expression of D1 dopamine receptors. J Neurochem 100: 416-428. (Pubitemid 46011002)
9. Donati RJ, Rasenick MM (2003). G protein signaling and the molecular basis of antidepressant action. Life Sci 73: 1-17. (Pubitemid 36519215)
10. Dziedzicka-Wasylewska M, Willner P, Papp M (1997). Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav Pharmacol 8: 607-618. (Pubitemid 27504709)
11. Fatemi SH, Folsom TD, Reutiman TJ, Braun NN, Lavergne LG (2010). Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex. Synapse 64: 550-555.
12. Fischette CT, Nock B, Renner K (1987). Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res 421: 263-279. (Pubitemid 18021634)
13. Gambarana C, Ghiglieri O, Tagliamonte A, D'Alessandro N, de Montis MG (1995). Crucial role of D1 dopamine receptors in mediating the antidepressant effect of imipramine. Pharmacol Biochem Behav 50: 147-151.
14. Gérard C, Martres MP, Lefèvre K, Miquel MC, Vergé D, Lanfumey L et al (1997). Immuno-localization of serotonin 5-HT6 receptorlike material in the rat central nervous system. Brain Res 746: 207-219. (Pubitemid 27060349)
15. Hamilton TJ, Wheatley BM, Sinclair DB, Bachmann M, Larkum ME, Colmers WF (2010). Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells. Proc Natl Acad Sci USA 107: 18185-18190.
16. Huzarska M, Zieliñski M, Herman ZS (2006). Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain. Eur J Pharmacol 532: 208-213.
17. Klempin F, Babu H, De Pietri Tonelli D, Alarcon E, Fabel K, Kempermann G (2010). Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Front Mol Neurosci 3: 14.
18. Klimek V, Nielsen M (1987). Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. Eur J Pharmacol 139: 163-169. (Pubitemid 17101118)
19. Kobayashi K (2009). Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders. Mol Neurobiol 39: 24-36.
20. Kobayashi K (2010). Hippocampal mossy fiber synaptic transmission and its modulation. Vitam Horm 82: 65-85.
21. Kobayashi K, Ikeda Y, Haneda E, Suzuki H (2008). Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. J Neurosci 28: 6272-6280.
22. Kobayashi K, Ikeda Y, Sakai A, Yamasaki N, Haneda E, Miyakawa T et al (2010). Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci USA 107: 8434-8439.
23. Kobayashi K, Ikeda Y, Suzuki H (2006). Locomotor activity correlates with modifications of hippocampal mossy fibre synaptic transmission. Eur J Neurosci 24: 1867-1873. (Pubitemid 44583471)
24. Kobayashi K, Ikeda Y, Suzuki H (2011a). Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine. Mol Brain 4: 12.
25. Kobayashi K, Poo M-M (2004). Spike train timing-dependent associative modification of hippocampal CA3 recurrent synapses by mossy fibers. Neuron 41: 445-454. (Pubitemid 38221046)
26. Kobayashi K, Suzuki H (2007). Dopamine selectively potentiates hippocampal mossy fibre to CA3 synaptic transmission. Neuropharmacology 52: 552-561. (Pubitemid 46123372)
27. Kobayashi K, Umeda-Yano S, Yamamori H, Takeda M, Suzuki H, Hashimoto R (2011b). Correlated alterations in serotonergic and dopaminergic modulations at the hippocampal mossy fiber synapse in mice lacking dysbindin. PLoS One 6: e18113.
28. Korff S, Stein DJ, Harvey BH (2009). Cortico-striatal cyclic AMPphosphodiesterase-4 signalling and stereotypy in the deer mouse: attenuation after chronic fluoxetine treatment. Pharmacol Biochem Behav 92: 514-520.
29. Kusuki T, Imahori Y, Ueda S, Inokuchi K (1997). Dopaminergic modulation of LTP induction in the dentate gyrus of intact brain. Neuroreport 8: 2037-2040. (Pubitemid 27314330)
30. Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM (2009). The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem 109: 1363-1374.
31. López-Giménez JF, Tecott LH, Palacios JM, Mengod G, Vilaró MT (2002). Serotonin 5-HT2C receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J Neurosci Res 67: 69-85.
32. Ludwig V, Schwarting RKW (2007). Neurochemical and behavioral consequences of striatal injection of 5,7-dihydroxytryptamine. J Neurosci Methods 162: 108-118. (Pubitemid 46527916)
33. Magariños AM, Verdugo JMG, McEwen BS (1997). Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA 94: 14002-14008. (Pubitemid 28009699)
34. Malberg JE, Blendy JA (2005). Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 26: 631-638. (Pubitemid 41636308)
35. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110. (Pubitemid 32042912)
36. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ (1990). Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10: 2587-2600.
37. Meltzer HY, Massey BW (2011). The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 11: 59-67.
38. Miller BH, Schultz LE, Gulati A, Cameron MD, Pletcher MT (2008). Genetic regulation of behavioral and neuronal responses to fluoxetine. Neuropsychopharmacology 33: 1312-1322. (Pubitemid 351521706)
39. Miyamoto D, Iijima M, Yamamoto H, Nomura H, Matsuki N (2011). Behavioural effects of antidepressants are dependent and independent on the integrity of the dentate gyrus. Int J Neuropsychopharmacol 14: 967-976.
40. Musazzi L, Cattaneo A, Tardito D, Barbon A, Gennarelli M, Barlati S et al (2009). Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants. BMC Neurosci 10: 48.
41. Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M (2001). Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21: 63-73. (Pubitemid 32155392)
42. Reader TA, Gauthier P (1984). Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA. J Neural Transm 59: 207-227. (Pubitemid 14104012)
43. Sahay A, Hen R (2007). Adult hippocampal neurogenesis in depression. Nat Neurosci 10: 1110-1115. (Pubitemid 47339960)
44. Sahay A, Scobie KN, Hill AS, O0Carroll CM, Kheirbek MA, Burghardt NS et al (2011). Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 472: 466-470.
45. Sampson D, Willner P, Muscat R (1991). Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology (Berl) 104: 491-495.
46. Sánchez C, Hyttel J (1999). Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19: 467-489. (Pubitemid 29283825)
47. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. (Pubitemid 36962615)
48. Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A et al (1992). D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berl) 106: 14-18.
49. Uhl GR, Hall FS, Sora I (2002). Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7: 21-26. (Pubitemid 34087875)
50. Vaswani M, Linda FK, Ramesh S (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27: 85-102. (Pubitemid 36131110)
51. Vergé D, Daval G, Marcinkiewicz M, Patey A, el Mestikawy S, Gozlan H et al (1986). Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6: 3474-3482. (Pubitemid 17208532)
52. Vidal R, Valdizán EM, Mostany R, Pazos A, Castro E (2009). Longterm treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain. J Neurochem 110: 1120-1127.
53. Vizuete ML, Venero JL, Traiffort E, Vargas C, Machado A, Cano J (1997). Expression of 5-HT7 receptor mRNA in rat brain during postnatal development. Neurosci Lett 227: 53-56. (Pubitemid 27239538)
54. Winstanley CA, Dalley JW, Theobald DEH, Robbins TW (2003). Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) 170: 320-331. (Pubitemid 37491612)
55. Yamasaki N, Maekawa M, Kobayashi K, Kajii Y, Maeda J, Soma M et al (2008). Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain 1: 6.